|
BL22307 |
3-Fuoroazetidine-3-carbonitrile oxalic acid |
2708280-62-8 |
C6H7FN2O4 |
190.1292 |
VIEW DETAILS > |
|
BL21050 |
4-(Prop-1-en-2-yl)benzoic acid |
1830-69-9 |
C10H10O2 |
162.1852 |
VIEW DETAILS > |
|
BL22272 |
EGF Receptor Substrate 2 (Phospho-Tyr5) |
149261-42-7 |
C54H82N13O24P |
1328.2753 |
VIEW DETAILS > |
|
BM03789 |
Insulin β Chain Peptide (15-23) |
247044-67-3 |
C44H72N12O13S |
1009.1801 |
VIEW DETAILS > |
|
BM03792 |
DOTATATE |
177943-88-3 |
C65H90N14O19S2 |
1435.6225 |
VIEW DETAILS > |
|
BM03810 |
Sulfo-CY-5.5 NHS ester tripotassium |
2419286-92-1 |
C44H42K3N3O16S4 |
1114.3697 |
VIEW DETAILS > |
|
BM04143 |
Mal-EGGGG-PEG8-amide-bis(deoxyglucitol) |
2360920-01-8 |
C55H94N10O31 |
1391.3833 |
VIEW DETAILS > |
|
BM06130 |
4-(2-Methoxyethyl)tetrahydro-2h-pyran-4-carboxylic acid |
1310224-13-5 |
C9H16O4 |
188.2209 |
VIEW DETAILS > |
|
BM04942 |
MC-Gly-Gly-Phe-Gly-(R)-Cyclopropane-Exatecan |
2414254-51-4 |
C55H60FN9O13 |
1074.1158 |
VIEW DETAILS > |
|
BM03586 |
Cardiotoxin Analog (CTX) IV (6-12) (TFA) |
2918768-05-3 |
C50H71F3N10O9 |
1013.1555 |
VIEW DETAILS > |